I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 17 studies | 37% ± 12% | |
| classical monocyte | 7 studies | 23% ± 7% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 7 studies | 21% ± 6% | |
| CD8-positive, alpha-beta T cell | 7 studies | 24% ± 9% | |
| plasma cell | 6 studies | 28% ± 12% | |
| hepatocyte | 5 studies | 67% ± 20% | |
| mast cell | 4 studies | 17% ± 1% | |
| conventional dendritic cell | 4 studies | 31% ± 13% | |
| gamma-delta T cell | 4 studies | 26% ± 13% | |
| precursor B cell | 4 studies | 29% ± 6% | |
| pro-B cell | 4 studies | 23% ± 3% | |
| B cell | 4 studies | 21% ± 2% | |
| pericyte | 4 studies | 17% ± 2% | |
| pancreatic A cell | 3 studies | 29% ± 6% | |
| type B pancreatic cell | 3 studies | 32% ± 9% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 3% | |
| IgG plasma cell | 3 studies | 17% ± 1% | |
| mature NK T cell | 3 studies | 28% ± 7% | |
| fibroblast | 3 studies | 18% ± 2% | |
| abnormal cell | 3 studies | 27% ± 13% |
